Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
As has been pointed out on here, the 2nd cohort in the RP trial have slightly *better* baseline vision than the first so presumably we have to manage our expectations and not expect as spectacular results as with the 1st. Personally I think it'll be a fantastic result if they experience any level of improvement. That would then help RENE determine the most suitable patients for commercial treatment in the future.
Any improvement would be fantastic not only for the patients concerned but it will validate that the impressive improvements in the 1st cohort was not just some kind of fluke. That's important with such a tiny sample size.
Apologies eggonaroll, I thought you'd cashed in and fled! I'm glad you're still around.
Looking really strong over the last couple of days, good times ahead.
... when you want him/her for some shameless ramping?
Gave it all the large then bottled it and sold out when it dropped 10p, no doubt.
LOL ... yes, a nice image that!
I suppose you've always got the potential leaking of information from the patients, their extended family and friends and the clinical practitioners overseeing the trials as well to consider. The point is the company should always release pertinent information (positive or negative) as soon as it becomes available to them.
The SP is only back to where it was "naturally" after the Fosun deal and later RNS confirming continued efficacy in the RP trial anyway so it's not exactly surging ahead with no news. It's just a recovery after a bit of selling IMO.
Of course a positive RNS would always be welcome nonetheless.
Well it's there for everyone to buy if you want in. The board have enough share options to make themselves very rich without needing to do any shady dealing anyhow.
The last couple of weeks seems to have successfully flushed out the doubters, short-term profit takers and weak holders, the sub-£3 brigade. Now we can power on from here.
£4 sooooooon :)
GLA
I thought (and still think) it will settle around the 275p mark but I'm pulling down the blinds now and going to preserve my sanity by not looking every 5 minutes and checking back in a couple of months.
Good luck folks! Keep the faith, keep your RENE and you'll twenty-bag from here :)
You beat me to it.
The company states: "The second cohort comprised three patients with a greater baseline level of visual acuity than those patients earlier in the study"
It's very clear they're going places and fast.
Expect exosome commercial deal very soon (that's IMO only) :)
Can't knock anyone taking a profit but for me this is such an exciting time for RENE I wouldn't dream of selling.
I want to see the results for the latest cohort of RP patients. If they've shown improvements I reckon were in business and in for 10-fold+ increases from here because it will dramatically increase the chances of the treatment getting to market.
Good luck all
http://www.reneuron.com/news/events/
ReNeuron is presenting at the following events.
Allogeneic Cell Therapies Summit
Start date: May 7, 2019
End date: May 9, 2019
Location: Boston, USA
Relax Mr Egg, this was always going to happen. Nothing goes up in a straight line; you need the dips to build the sustained rise.
https://www.otcmarkets.com/stock/RNUGF/overview
Shows volume
I really expected it to pull back a bit today but it's a great sign it seems to sit happily above £3 now.
This is just the beginning ...
I hope you're right Egg but the key is not to become disillusioned if profit takers do knock it back a bit. Be bold, hold and you'll reap the rewards.
... my RENE is not for selling.
I would expect the SP to fall back a bit now, maybe settling around £2.75 until further news but I'm not risking selling a single share. I believe they've got a real shot at getting the RP treatment to market and if they do it'll be many many multiples of today's price. There is also the strong possibility of more short term drivers in the meantime making it far too risky in my opinion to attempt to trade in and out.
Good luck folks, especially fellow LTHs.
1 x bottle of hat sauce
Brand new unopened. Not required hence selling.
What are you hoping for from the RNS?
I'm hoping they will give us some results from the 2nd cohort of patients and report a similar improvement in their vision. And no deterioration in the 1st cohort.
That's it. I'm not expecting anything more than that, but that would be explosive in of itself I should think.
If the efficacy is repeated in the 2nd cohort of patients and maintained in the 1st cohort then it's got a very real chance of making it to market and that means many multiples of today's price.
That's why I'm not parting with a single share. If the efficacy drops off or it seems like the incredible results in the first 3 patients were just a freak lucky break then of course the SP will fall off a cliff.
But I like the potential; it could easily go 20x current value or 1/4 or the current value. I like the odds and crucially so does a large Chinese pharma, big investors and members of the board, so I'm siding with them.